![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PHC Receives EU-MDR Certification for Motorized Drug Injection Device
PHC Receives EU-MDR Certification for Motorized Drug Injection Device
The in vitro diagnostics division of Tokyo, Japan-based PHC has received certification under the EU’s Medical Devices Regulation (EU-MDR) for a motorized drug injection device that delivers anti-inflammatory medications called tumor-necrosis factor (TNF) inhibitors.
The APP-1000 device features a screen with illustrations to make it easier for patients to use and a choice of three injection speeds. The device allows patients to self-inject TNF inhibitors at a touch of a button, without the need for measurement or preparation.
Dosing history stored in the device’s memory can be transferred via Bluetooth to a smartphone, so patients and doctors can check the dosing record remotely.
The company plans to launch the APP-1000 in EU countries in July.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct